article Drug Discovery

Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR

Alexander Tropsha, Olexandr Isayev, Alexandre Varnek, Gisbert Schneider, Artem Cherkasov

Nat. Rev. Drug Discov. Vol. 23 (2) pp. 141–155 2024

Keywords

Cite This Paper

@article{Tropsha2024,
  author = {Tropsha, Alexander and Isayev, Olexandr and Varnek, Alexandre and Schneider, Gisbert and Cherkasov, Artem},
  title = {Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR},
  year = {2024},
  journal = {Nat. Rev. Drug Discov.},
  volume = {23},
  number = {2},
  pages = {141--155},
  doi = {10.1038/s41573-023-00832-0},
  keywords = {QSAR, deep learning, drug discovery},
  researchAreas = {drug-discovery},
  researchArea = {drug-discovery},
  featured = {true}
}

Related Research Areas

Drug Discovery

Related Publications

2025

All that glitters is not gold: Importance of rigorous evaluation of proteochemometric models

Avdiunina P., Jamal S., Gusev F., Isayev O.

(2025)

Drug Discovery

Proteochemometric models (PCM) are used in computational drug discovery to leverage both protein and ligand representations for bioactivity prediction.

DOI

2022

cited74

Generative and reinforcement learning approaches for the automated de novo design of bioactive compounds

Korshunova M., Huang N., Capuzzi S., Radchenko D. S., Savych O., Moroz Y. S., Wells C. I., Willson T. M., Tropsha A., Isayev O.

Communications Chemistry, 5 (2022)

Generative Ai

Drug Discovery

Experiment Automation

AbstractDeep generative neural networks have been used increasingly in computational chemistry for de novo design of molecules with desired properties.

DOI

2021

cited66

Crowdsourced mapping of unexplored target space of kinase inhibitors

Cichońska A., Ravikumar B., Allaway R. J., Wan F., Park S., Isayev O., Li S., Mason M., Lamb A., Tanoli Z., Jeon M., Kim S., Popova M., Capuzzi S., Zeng J., Dang K., Koytiger G., Kang J., Wells C. I., Willson T. M., Tan M., Huang C., Shih E. S. C., Chen T., Wu C., Fang W., Chen J., Hwang M., Wang X., Ben Guebila M., Shamsaei B., Singh S., Nguyen T., Karimi M., Wu D., Wang Z., Shen Y., Öztürk H., Ozkirimli E., Özgür A., Lim H., Xie L., Kanev G. K., Kooistra A. J., Westerman B. A., Terzopoulos P., Ntagiantas K., Fotis C., Alexopoulos L., Boeckaerts D., Stock M., De Baets B., Briers Y., Luo Y., Hu H., Peng J., Dogan T., Rifaioglu A. S., Atas H., Atalay R. C., Atalay V., Martin M. J., Jeon M., Lee J., Yun S., Kim B., Chang B., Turu G., Misák Á., Szalai B., Hunyady L., Lienhard M., Prasse P., Bachmann I., Ganzlin J., Barel G., Herwig R., Oršolić D., Lučić B., Stepanić V., Šmuc T., Oprea T. I., Schlessinger A., Drewry D. H., Stolovitzky G., Wennerberg K., Guinney J., Aittokallio T.

Nature Communications, 12 (2021)

Drug Discovery

Abstract Despite decades of intensive search for compounds that modulate the activity of particular protein targets, a large proportion of the human kinome remains as yet undrugged.

DOI

2020

cited63